Two Sigma Investments’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $896K | Sell |
|
|||||
|
2025
Q1 | $981K | Buy |
|
|||||
|
2024
Q4 | $162K | Sell |
|
|||||
|
2024
Q3 | $378K | Buy |
|
|||||
|
2024
Q2 | $87K | Sell |
|
|||||
|
2024
Q1 | $182K | Sell |
|
|||||
|
2023
Q4 | $318K | Sell |
|
|||||
|
2023
Q3 | $399K | Buy |
|
|||||
|
2023
Q2 | $582K | Buy |
|
|||||
|
2023
Q1 | $186K | Sell |
|
|||||
|
2022
Q4 | $239K | Sell |
|
|||||
|
2022
Q3 | $352K | Buy |
|
|||||
|
2022
Q2 | $357K | Sell |
|
|||||
|
2022
Q1 | $827K | Sell |
|
|||||
|
2021
Q4 | $2.24M | Buy |
|
|||||
|
2021
Q3 | $680K | Sell |
|
|||||
|
2021
Q2 | $827K | Sell |
|
|||||
|
2021
Q1 | $1.07M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $138K | Sell |
|
|||||
|
2020
Q1 | $209K | Sell |
|
|||||
|
2019
Q4 | $591K | Buy |
|
|||||
|
2019
Q3 | $193K | Buy |
|
|||||
|
2019
Q2 | $175K | Sell |
|
|||||
|
2019
Q1 | $257K | Sell |
|
|||||
|
2018
Q4 | $252K | Buy |
|